Table 1. Serum proteins potentially relevant to NSCLC confirmed by IMDL and label free quantification in the discovery phase.
Protein Name | Gene symbol | IPI ID | SwissPort/Trembl | Normalized average peptide hitsa | Referrences of NSCLCb | ||
N | AD | SCC | |||||
Up-regulated in AD and SCC | |||||||
Alpha-1-antitrypsin | SERPINA1 | IPI00553177 | P01009 | 1396.7 | 2393.4 | 2460.0 | [31], [56] |
C4b-binding protein alpha chain | C4BPA | IPI00021727 | P04003 | 164.8 | 264.5 | 264.1 | [57], [58] |
C-reactive protein | CRP | IPI00022389 | P02741 | 0.0 | 15.2 | 3.5 | [32] |
Haptoglobin | HP | IPI00641737 | P00738 | 337.2 | 764.3 | 693.3 | [29], [32], [56], [57] |
Haptoglobin-related protein | HPR | IPI00607707 | P00739 | 93.4 | 369.5 | 295.9 | [32] |
Hemoglobin subunit alpha | HBA1/HBA2 | IPI00410714 | P69905 | 6.8 | 38.3 | 21.5 | [30] |
Hemopexin | HPX | IPI00022488 | P02790 | 374.2 | 703.3 | 680.5 | [29] |
Leucine-rich alpha-2-glycoprotein | LRG1 | IPI00022417 | P02750 | 24.7 | 73.6 | 47.4 | [32] |
Prothrombin | F2 | IPI00019568 | P00734 | 156.4 | 185.8 | 203.9 | [32] |
Serotransferrin | TF | IPI00022463 | P02787 | 2076.6 | 2781.6 | 2931.8 | [56] |
Serum amyloid A protein | SAA1 | IPI00552578 | P02735 | 2.2 | 87.8 | 51.3 | [29], [59] |
Serum amyloid A2 | SAA2 | IPI00006146 | P02735 | 0.6 | 88.9 | 37.4 | [60] |
Transthyretin | TTR | IPI00022432 | P02766 | 326.1 | 507.0 | 779.5 | [30], [31], [60] |
Up-regulated in AD | |||||||
Complement component 4a | C4A | IPI00744893 | P0C0L4 | 55.4 | 99.5 | 53.8 | [32] |
IGHA1 protein | IGHA1 | IPI00166866 | 288.3 | 516.6 | 366.4 | [58] | |
Ig alpha-2 chain C region | IGHA2 | IPI00641229 | P01877 | 153.5 | 355.6 | 253.4 | [58] |
IGHA2 protein | IGHA2 | IPI00644497 | 45.8 | 170.0 | 109.7 | ||
Up-regulated in SCC | |||||||
Apolipoprotein C-III | APOC3 | IPI00657670 | P02656 | 1.0 | 3.5 | 5.3 | [31] |
Ceruloplasmin | CP | IPI00017601 | P00450 | 167.1 | 61.7 | 179.2 | [57] |
Clusterin | CLU | IPI00291262 | P10909 | 63.2 | 64.5 | 86.6 | [32], [58] |
Up-regulated in N | |||||||
Alpha-2-macroglobulin | A2M | IPI00478003 | P01023 | 3356.6 | 2808.8 | 2802.3 | [32] |
Angiotensinogen | AGT | IPI00032220 | P01019 | 235.8 | 127.6 | 121.4 | [32] |
Antithrombin-III | SERPINC1 | IPI00032179 | P01008 | 747.5 | 341.0 | 587.6 | [29] |
Apolipoprotein L1 | APOL1 | IPI00186903 | O14791 | 28.9 | 11.7 | 21.5 | [61] |
Complement C3 | C3 | IPI00783987 | P01024 | 3380.1 | 3341.6 | 2639.9 | [32], [58] |
Gelsolin | GSN | IPI00026314 | P06396 | 101.3 | 47.5 | 67.2 | [32], [61] |
Plasminogen | PLG | IPI00019580 | P00747 | 370.3 | 247.6 | 279.3 | [32] |
Tetranectin | CLEC3B | IPI00009028 | P05452 | 8.7 | 1.9 | 3.7 | [32] |
Averaged PSMs (peptide hits) in Normal (N), AD and SCC group.
Reference listed were closely related to NSCLC and all reported the identical up or down regulation trend with our results.